高级搜索
趋化因子受体CXCR4在甲状腺癌中的表达[J]. 肿瘤防治研究, 2008, 35(02): 107-109. DOI: 10.3971/j.issn.1000-8578.2047
引用本文: 趋化因子受体CXCR4在甲状腺癌中的表达[J]. 肿瘤防治研究, 2008, 35(02): 107-109. DOI: 10.3971/j.issn.1000-8578.2047
Expression of CXCR4 Chemokine Receptor in Thyriod Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(02): 107-109. DOI: 10.3971/j.issn.1000-8578.2047
Citation: Expression of CXCR4 Chemokine Receptor in Thyriod Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(02): 107-109. DOI: 10.3971/j.issn.1000-8578.2047

趋化因子受体CXCR4在甲状腺癌中的表达

Expression of CXCR4 Chemokine Receptor in Thyriod Cancer

  • 摘要: 目的探讨趋化因子受体CXCR4在甲状腺癌中的表达及临床意义,为临床治疗甲状腺癌寻求新的治疗靶点提供依据。方法采用免疫组化SP染色法检测甲状腺癌、结节性甲状腺肿、甲状腺腺瘤及正常甲状腺组织中CXCR4表达差异,以及CXCR4在甲状腺癌中的表达与患者肿瘤病理类型、淋巴结转移状态、年龄及性别的关系。结果CXCR4在甲状腺癌组织中高表达,与结节性甲状腺肿、甲状腺腺瘤及正常甲状腺组织中表达差异有统计学意义,而且与患者淋巴结转移状态、病理类型密切相关,与患者年龄、性别无关。结论CXCR4在甲状腺癌的发生发展中可能起到重要作用,CXCR4在甲状腺癌中高表达,与患者淋巴结转移状态、病理类型密切相关,可作为甲状腺癌患者预后的指标,本研究为临床寻找新的甲状腺癌治疗靶点提供了重要依据。

     

    Abstract: Objective  To investigate the expression and significance of chemokine receptor (CXCR4) in thyroid cancer, and provide basis for seeking new target in thyroid cancer therapy. Methods  SP immuno2 histochemical technique was used to test the different expression of chemokine receptor (CXCR4) in tis2 sues of thyroid cancer, nodular goiter, thyroid adenoma and normal thyroid tissues. The relation of CX2 CR4 expression in thyroid cancer with pathological type, the state of lymphatic metastasis, age and sex was analyzed. Results  The expressional level of CXCR4 in thyroid cancer is high, and is closely related with pathological type and the state of lymphatic metastasis, however positive expression did not related to age and sex. Conclusion  CXCR4 may cont ribute to the function in occurrence and development of thy2 roid cancer. The expression of CXCR4 in thyroid cancer might be used as a marker to evaluate prognosis and provide the important basis for seeking new curing target s of thyroid cancer therapy in clinic.

     

/

返回文章
返回